Targacept, Inc. (Nasdaq: TRGT) said its collaboration and license agreement with AstraZeneca (NYSE: AZN) for the global development and commercialization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE